Investor Presentation

November 4, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C/1, Block G, Dalal Street, Mumbai - 400001 Bandra-Kurla Complex, Bandra (E), Mumbai - 400051 Scrip Code: 500135 Trading Symbol: EPL Sub. : Investor Presentation - EPL Limited (“Company”) Ref. : 1. Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (“SEBI LODR Regulations”) 2. ISIN: INE255A01020 Sir/ Madam, In terms of the above referred provisions of the SEBI LODR Regulations and in furtherance of our intimation dated October 28, 2026 with respect to the Conference call for Analysts/ Investors scheduled to be held on November 4, 2026, please find enclosed herewith, the Investor Presentation on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026. The said Investor Presentation will also be available on the website of the Company i.e. https://www.eplglobal.com/. This is for your information and records. Thanking you. Yours faithfully, For EPL Limited Onkar Ghangurde Head - Legal, Company Secretary & Compliance Officer ICSI Membership No. A30636 Encl.: As above LEAOl PACK EPL LIMITED Q2FY27 Earnings Presentation PLATINUM ecovadis Sustainability Rating AUG 2025 Safe Harbour Certain statements in this presentation concerning our future growth prospects are forward-looking statements. The Company cautions that, by their nature, forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in packaging industry including those factors which may affect our cost advantage, wage increases, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, industry segment concentration, our ability to manage our operations, reduced demand for packaging products in our key focus areas, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which is EPL (Formerly known as Essel Propack Limited) has made strategic investments, withdrawal of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies, and unauthorized use of our intellectual property and general economic conditions affectingourindustry.TheCompanydoesnotundertaketoupdateanyforward-lookingstatementsthatmaybemadefromtimeto timeby oronbehalfoftheCompany. EPL Limited 2 Q2FY27 Earnings Presentation Key topics • Q2FY27 Highlights and Financial Performance • Update on Key Initiatives • Growth Drivers • Sustainability: Product, Process, People • Awards and Recognition • Looking Ahead • Appendix EPL Limited 3 Q2FY27 Earnings Presentation Q2FY27: Strong Quarter with 30.0% Revenue Growth and 17.6% EBITDA growth Delivered strong revenue growth of 30.0%, driven by broad based momentum across categories and regions. Excluding commodity pass-through pricing, underlying revenue growth stood at 20.3%, reflecting strong acceleration in core business performance. 2 All regions delivered strong growth with EAP leading the pack at 40.2%. AMESA, Americas and Europe have grown at 28.0%, 25.3% and 30.4% respectively. Underlying EBITDA margin stood at 20.4% growing 17.6% vs PY demonstrating resilience in our operating model during volatile operating environment. However, reported EBITDA is at 18.9% due to commodity inflation led pricing pass through. 4 PAT growth of 5.6% impacted by higher depreciation (due to ahead of the curve investments), higher ETR (due to lower Europe profit) and FX losses. We expect PAT growth to recover in coming quarters. 5 Return on Capital Employed (‘ROCE’) continues to be strong at 18.2%. EPL Limited 4 Q2FY27 Earnings Presentation Our Investments are reflecting in growth acceleration Stepped Up Investments… ..resulting in double digit revenue growth over last 6 quarters Underlying Growth 20.0% 20.3% 1 Ahead of the curve CAPEX investment in new technologies/capabilities 17000 35% 15,674 16000 15000 30.0% 13,879 14000 13,005 25.3% 13000 12,059 20% Extrusion Lines Printing Lines New Tooling Investment 11,488 12000 11,079 17.6% 15% 11000 13.3% 2 Opexinvestment in building differentiated capabilities 10000 10.0% 11.0% 9000 8000 0% Q1 FY 26 Q2 FY 26 Q3 FY 26 Q4 FY 26 Q1 FY 27 Q2 FY 27 I- -_ _ _ • Acquiring new customer in B&C (80+ customers) Value-Added Processes Innovation CoE Hunting Manpower (Metalization) J • Wallet share gain in Oral with MNC’s EPL Limited 5 Q2FY27 Earnings Presentation Q2FY27 Consolidated Financial Highlights (INR million) Revenue from Operations EBITDA and EBITDA Margins1 EBIT and EBIT Margins 15,674 20.9% 18.9% 13.0% 11.6% 12,059 2,516 2,960 1,572 1,826 30.0% 17.6% 16.2% Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 PAT and EPS Net Debt and Net Debt/ LTM EBITDA ROCE D D D D 18.7% 18.2% 3.26 3.44 0.51x 0.62x 1,043 1,101 -51 bps 6,562 4,636 5.6%. Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27  Revenuegrowth byregion– AMESA(+28.0%),India(+30.5%),EAP(+40.2%),Americas (+25.3%),Europe(+30.4%)  UnderlyingEBITDAmargin @20.4%.Reported EBITDA@18.9% duetocommodity inflation ledpricingincludedinrevenue.  PAT growth impacted by higher depreciation (due to ahead of the curve investments), higher ETR (due to lower Europe profit) and FX losses.WeexpectPATgrowth torecoverincomingquarters.  Netdebtincreaseduetoaheadofthecurvecapexinvestmentsandhigherworking capital duetomiddleeastcrisis. EPL Limited Q2FY27 Earnings Presentation 6 1EBITDA is excluding Fxgain/(loss). In the publication Fxgain is included in Other income and Fxlosses are part of Other Expenses. Key Growth and Capital Efficiency KPIs (INR million) Q2FY26 Q2FY27 Growth 12,059 15,674 Revenue 30.0% Growth EBITDA 2,516 2,960 17.6% EPS (INR) 3.26 3.44 5.4% As of Sep’25 As of Sep’26 ROCE 18.7% 18.2% Capital Net Debt 4,636 6,562 Efficiency YTDFY26 YTDFY27 Capex 1,681 3,150 EPL Limited Q2FY27Earnings Presentation 7 Consistent Mid-teens EBITDA growth; Underlying Margin at 20.4% I EBITDA: 5,572Mn EBITDA: 9,724Mn t--------•• I Margin: 18.9% Margin: 20.4% I (Underlying Margin 20.0%) 8,396 I 22.0% 20.9% I 8,500 20.5% I 21.0% 7,143 19.9% 20.1% 20.2% I -- -- 20.4%Unde 7,500 rlying ---- 19.6% EBITDA Margin 20.0% 5,991 6,500 19.0% 18.2% 5,500 18.9% 18.8% 18.0% 4,500 17.0% 16.2% 2,516 2,632 2,612 2,960 3,500 2,268 2,308 16.0% 2,500 15.0% 1,500 14.0% 500 FY23 FY24 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q2 FY27 EBITDA Growth 19.2% 17.5% 18.1% 16.1% 11.9% 17.2% 15.2% 17.6% YTD FY27 EBITDA Growth +16.5% FY26 EBITDA Growth +15.8% EPL Limited Q2FY27 Earnings Presentation 8 *EBITDA is excluding Fxgain/(loss). In the publication Fxgain is included in Other income and Fxlosses are part of Other Expenses. Key topics • Q2FY27 Highlights and Financial Performance • Update on Key Initiatives • Growth Drivers • Sustainability: Product, Process, People • Awards and Recognition • Looking Ahead • Appendix EPL Limited Q2FY27 Earnings Presentation Accelerating Growth Momentum B&C* continued strong performance with robust 42.9% growth fueled by strong momentum across regions. With continued investments, management focus and execution discipline, we remain confident in sustaining growth momentum. AMESA: Delivered strong revenue growth of 28.0% led by sustained B&C momentum and continued recovery in Oral care; India grew at solid 30.5%. EAP – Delivered outstanding revenue growth of 40.2% driven by strong momentum in B&C and a continued focus on premiumization in Oral Care. Americas – Delivered strong broad based growth of 25.3 [Showing first 8,000 characters — download PDF for full document]